Search - tctmd.com

Displaying 241 - 260 of 300

Sort: Relevancy | Date

News Daily News

A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes

Yael L. Maxwell

April 25, 2016

News Daily News

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

Michael O'Riordan

April 14, 2016

News Daily News

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

Michael O'Riordan

April 12, 2016

News Daily News

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

Todd Neale

March 01, 2016

News Daily News

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Todd Neale

March 01, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Daily News

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Todd Neale

January 25, 2016

News Daily News

心梗后、PCI 后以及 CAD 患者的他汀类药物绩效指标发生修订

Michael O'Riordan

December 20, 2015

News Daily News

Revisión de las Métricas de Rendimiento para el Uso de Estatinas Post-IM, Post-PCI en Pacientes EAC

Michael O'Riordan

December 20, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Daily News

Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke

L.A. McKeown

November 03, 2015

News Daily News

尽管存在缺点和操作繁琐，但电子病例仍可为急性心肌梗死患者带来有意义的益处

Yael L. Maxwell

October 30, 2015

News Daily News

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Yael L. Maxwell

October 30, 2015

News Daily News

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

Yael L. Maxwell

October 30, 2015

Presentation

Modest Associations Between EHR Use andAcute MI Quality of Care and Outcomes

Presenter: Jonathan R. Enriquez

October 29, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

Advertisement

A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes

Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

心梗后、PCI 后以及 CAD 患者的他汀类药物绩效指标发生修订

Revisión de las Métricas de Rendimiento para el Uso de Estatinas Post-IM, Post-PCI en Pacientes EAC

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke

尽管存在缺点和操作繁琐，但电子病例仍可为急性心肌梗死患者带来有意义的益处

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

Modest Associations Between EHR Use andAcute MI Quality of Care and Outcomes

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Discussion Highlights Merits, Limitations of Small Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content